fingolimod hydrochloride has been researched along with Memory Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkes, D; Bieberich, E; Crivelli, SM; De Vries, HE; Dehairs, J; den Hoedt, S; Derua, R; Giovagnoni, C; Kruining, DV; Losen, M; Luo, Q; Mané-Damas, M; Martinez-Martinez, P; Mulder, MT; Swinnen, JV; Waelkens, E; Walter, J; Wijnands, EPM | 1 |
| Ali Mard, S; Farbood, Y; Ghafouri, S; Hajipour, S; Khombi Shooshtari, M; Moradi Chameh, H; Sarkaki, A; Sistani Karampour, N | 1 |
| Carreras, I; Dedeoglu, A; Jung, Y; Lopez-Benitez, J; Tognoni, CM | 1 |
| Casarotto, P; Castrén, E; Delanoe, K; Edelmann, E; Endres, T; Gottmann, K; Kartalou, GI; Lesnikova, A; Lessmann, V; Marie, H; Pousinha, P; Salgueiro-Pereira, AR | 1 |
| Ahmadiani, A; Asle-Rousta, M; Dargahi, L; Kolahdooz, Z; Oryan, S | 1 |
| Fukumoto, K; Horiuchi, H; Jin, S; Kawanokuchi, J; Mizoguchi, H; Mizuno, T; Suzumura, A; Takeuchi, H | 1 |
| Ahmadiani, A; Dargahi, L; Khallaghi, B; Mohamed, Z; Naidu, M; Nasoohi, S; Omidbakhsh, R; Rajabli, B | 1 |
| Ahmadiani, A; Asle-Rousta, M; Dargahi, L; Kolahdooz, Z; Nasoohi, S | 1 |
| Haghani, M; Keshavarz, S; Namavar, MR; Nazari, M; Rafati, A | 1 |
| Cao, Y; Gao, J; Hao, Y; Liang, S; Sun, C; Wang, X; Wu, H; Wu, L; Xia, W | 1 |
10 other study(ies) available for fingolimod hydrochloride and Memory Disorders
| Article | Year |
|---|---|
FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
Topics: Alzheimer Disease; Animals; Apolipoprotein E4; Brain; Ceramides; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Memory Disorders; Mice; Sphingolipids | 2022 |
Fingolimod Administration Following Hypoxia Induced Neonatal Seizure Can Restore Impaired Long-term Potentiation and Memory Performance in Adult Rats.
Topics: Animals; Epilepsy; Female; Fingolimod Hydrochloride; gamma-Aminobutyric Acid; Hippocampus; Hypoxia; Long-Term Potentiation; Male; Memory Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Seizures | 2023 |
Fingolimod mitigates memory loss in a mouse model of Gulf War Illness amid decreasing the activation of microglia, protein kinase R, and NFκB.
Topics: Amnesia; Animals; Disease Models, Animal; Fingolimod Hydrochloride; Gulf War; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Microglia; Neuroinflammatory Diseases; NF-kappa B; Persian Gulf Syndrome; Protein Kinases; Pyridostigmine Bromide | 2023 |
Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Astrocytes; Disease Models, Animal; Fingolimod Hydrochloride; Hippocampus; Humans; Inflammation; Memory Disorders; Mice; Mice, Transgenic; Microglia; Presenilin-1; Synapses | 2020 |
FTY720 (fingolimod) attenuates beta-amyloid peptide (Aβ42)-induced impairment of spatial learning and memory in rats.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Fingolimod Hydrochloride; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Peptide Fragments; Propylene Glycols; Rats; Rats, Wistar; Sphingosine | 2013 |
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Association Learning; Brain; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Exploratory Behavior; Fingolimod Hydrochloride; Hippocampus; Male; Memory Disorders; Mice, Inbred C57BL; Neuroprotective Agents; Peptide Fragments; Propylene Glycols; Recognition, Psychology; Sphingosine; Up-Regulation | 2014 |
Fingolimod affects gene expression profile associated with LPS-induced memory impairment.
Topics: Animals; Avoidance Learning; Brain; Caspase 3; Dark Adaptation; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-1beta; Lipopolysaccharides; Male; Memory Disorders; Nerve Tissue Proteins; Propylene Glycols; Rats; Rats, Wistar; Sphingosine; Transcriptome; Tumor Necrosis Factor-alpha | 2014 |
Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Fingolimod Hydrochloride; Inflammation; Lipopolysaccharides; Lysophospholipids; Male; Maze Learning; Memory Disorders; Oxadiazoles; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; Thiophenes; Tumor Necrosis Factor-alpha | 2015 |
Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia.
Topics: Animals; Avoidance Learning; Brain Infarction; Disease Models, Animal; Fingolimod Hydrochloride; Hippocalcin; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Long-Term Potentiation; Lymphocytes; Male; Memory Disorders; Neurologic Examination; Neuronal Plasticity; Neutrophils; Rats; Rats, Sprague-Dawley; Reperfusion; Time Factors | 2016 |
Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autistic Disorder; Brain-Derived Neurotrophic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Inflammation; Interleukin-1beta; Interleukin-6; Learning; Male; Malondialdehyde; Memory Disorders; Oxidative Stress; Oxidoreductases; Pyramidal Cells; Rats; Rats, Wistar; Social Behavior | 2017 |